OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their robustness in expressing complex biologics. Optimizing these processes involves adjusting various factors, including cell line development, media composition, and bioreactor conditions. A key goal is to amplify antibody yield while minimizing production expenses